{"title":"与精神分裂症和精神病相关的谷氨酸药理模型:受体占用正常化方法可以减少动物和人类实验之间的差距吗?","authors":"M. Rafter, K. Fone, P. Moran","doi":"10.1016/B978-0-12-800981-9.00010-9","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":93003,"journal":{"name":"Handbook of behavioral neuroscience","volume":"23 1","pages":"139-174"},"PeriodicalIF":0.0000,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/B978-0-12-800981-9.00010-9","citationCount":"4","resultStr":"{\"title\":\"Glutamate Pharmacological Models Relevant to Schizophrenia and Psychosis: Can a Receptor Occupancy Normalization Approach Reduce the Gap between Animal and Human Experiments?\",\"authors\":\"M. Rafter, K. Fone, P. Moran\",\"doi\":\"10.1016/B978-0-12-800981-9.00010-9\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":93003,\"journal\":{\"name\":\"Handbook of behavioral neuroscience\",\"volume\":\"23 1\",\"pages\":\"139-174\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2016-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/B978-0-12-800981-9.00010-9\",\"citationCount\":\"4\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Handbook of behavioral neuroscience\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/B978-0-12-800981-9.00010-9\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Handbook of behavioral neuroscience","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/B978-0-12-800981-9.00010-9","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Glutamate Pharmacological Models Relevant to Schizophrenia and Psychosis: Can a Receptor Occupancy Normalization Approach Reduce the Gap between Animal and Human Experiments?